新闻
ARCT
--
0.00%
--
Benzinga 的最高评级升级,2021 年 7 月 2 日降级
 
Benzinga · 07/02 14:08
12 只医疗保健股在周五的盘前交易时段内移动
 
Benzinga · 07/02 12:14
Cantor Fitzgerald 以增持评级开始对 Arcturus Therapeutics 的报道,宣布目标价为 71 美元
Cantor Fitzgerald analyst Brian Cheng initiates coverage on Arcturus Therapeutics (NASDAQ:ARCT) with a Overweight rating and announces Price Target of $71.
Benzinga · 07/02 11:17
高盛分析师以 29 美元的目标价启动 Arcturus Therapeutics Holdings 中性
MT Newswires · 06/25 10:16
资本使用回报率概览:Arcturus Therapeutics
During Q1, Arcturus Therapeutics's (NASDAQ:ARCT) reported sales totaled $2.13 million. Despite a 85.53% in earnings, the company posted a loss of $57.67 million. In Q4, Arcturus Therapeutics brought in $2.24 million in sales but lost $31.08 million in earn...
Benzinga · 06/24 13:50
美国疾控中心发现基于m-RNA的COVID-19疫苗接种与心脏炎症可能存在关联
美国疾控中心发现基于m-RNA的COVID-19疫苗接种与心脏炎症可能存在关联
智通财经 · 06/24 01:55
Benzinga 的最高评级升级,2021 年 6 月 21 日降级
 
Benzinga · 06/21 14:15
12 只医疗保健股在周一的盘前交易时段内移动
 
Benzinga · 06/21 12:12
周一最大的 10 个目标价格变化
SVB Leerink raised Natera, Inc. (NASDAQ: NTRA) price target from $140 to $160. Natera shares fell 0.4% to close at $102.88 on Friday.
Benzinga · 06/21 11:53
巴克莱将 Arcturus Therapeutics 从等重减至减持,目标价从 33 美元降至 25 美元
MT Newswires · 06/21 06:14
研究 Arcturus Therapeutics 的资本使用回报
In Q1, Arcturus Therapeutics (NASDAQ:ARCT) posted sales of $2.13 million. Earnings were up 85.53%, but Arcturus Therapeutics still reported an overall loss of $57.67 million. Arcturus Therapeutics collected $2.24 million in revenue during Q4, but reported ...
Benzinga · 06/08 15:35
Baird 以 31 美元的目标价在中性启动 Arcturus Therapeutics
MT Newswires · 06/04 11:24
俄罗斯:TotalEnergies 从 Novatek 收购 Arctic Transshipment LLC 10% 的股份
Regulatory News: TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TOT) has signed a Sale and Purchase Agreement (SPA) with Novatek to acquire 10% of Arctic...
marketwatch.com · 06/03 13:42
Arcturus 获得 Primordial 用于人类和动物治疗的 RNA 聚合酶的独家许可
MT Newswires · 06/02 11:02
俄罗斯军队寻求在北极超越美国
The Arctic is the last geopolitical battleground where Moscow holds the advantage over Washington and Beijing, both of which are trying to expand their presence in the region.
marketwatch.com · 05/25 09:30
灰鲸被认为在大西洋绝种。那么沃利是如何离开里维埃拉的呢?
Researchers say that receding Arctic sea ice might have confused the whale during its annual Pacific migration.
marketwatch.com · 05/16 16:00
每日生物技术动向:由于DefenCath NDA的重新提交延迟,CorMedix下滑,Apellis等待FDA决定,Vera Therapeutics首次亮相
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13)
Benzinga · 05/14 11:59
每日生物技术动向:密涅瓦(Minerva),InflaRx报告阳性数据读数,亚马逊上提供的Lucira COVID-19测试套件,苍鹭的决策日
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11)
Benzinga · 05/12 12:57
-乙由于支出增加,莱利将Arcturus Therapeutics的价格目标从35美元下调至23美元,维持其卖出评级
MT Newswires · 05/12 09:10
Arcturus Therapeutics(ARCT)获得B.Riley Financial的卖出评级
B.Riley Financial analyst Mayank Mamtani reiterated a Sell rating on Arcturus Therapeutics (ARCT) today and set a price target of $23.00. The company's
SmarterAnalyst · 05/12 06:05
微牛提供丰富的实时ARCT股票新闻,让你可以通过多个平台了解ARCT股票行情最新动态,这些免费的Arcturus医疗新闻可以帮助你做出明智投资。
ARCT 简况
Arcturus Therapeutics Holdings Inc是一家临床阶段的信使核糖核酸(mRNA)药品和疫苗公司。该公司的技术包括LUNAR脂质介导的递送、STARR mRNA技术和mRNA药物以及药物生产。它的核糖核酸(RNA)治疗候选药物产品线包括治疗鸟氨酸转氨酶(OTC)缺乏症、囊性纤维化、三型糖原贮积病、乙型肝炎、非酒精性脂肪性肝炎(NASH)以及用于严重急性的自我复制mRNA疫苗的计划呼吸综合征冠状病毒二型(SARS-CoV-2)。其RNA治疗平台可用于各种核酸药物,包括信使RNA、小干扰RNA、复制子RNA、反义RNA、microRNA、脱氧核糖核酸(DNA)和基因编辑治疗剂。该公司专注于肝脏和呼吸系统疾病。